Summary:
- This article discusses a new cancer treatment approach called "Engineered T-cell Therapy" which involves modifying a patient's own immune cells to recognize and attack cancer cells.
- The treatment involves extracting T-cells from the patient, genetically engineering them to target specific cancer proteins, and then reinfusing the modified T-cells back into the patient to fight the cancer.
- Early clinical trials have shown promising results in treating certain types of blood cancers, and researchers are now exploring the potential of this approach for solid tumors as well.